Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond — De Clercq Erik (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
Shared by
De Clercq Erik
KU Leuven
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
Article
2011
en
Authors
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1999
Antitumor Potential of Acyclic Nucleoside Phosphonates
De Clercq Erik
,
Graciela Andreï
,
Jan Balzarini
,
Sigrid Hatse
,
Sandra Liekens
,
Lieve Naesens
,
Johan Neyts
,
Robert Snoeck
Article
2009
C-1 Antiviral activity of acyclic and cyclic nucleoside phosphonates
De Clercq Erik
Article
1995
The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
Lieve Naesens
,
Jan Balzarini
,
De Clercq Erik
Article
2006
The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective
De Clercq Erik
Article
2003
Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.